India, Nov. 9 -- AbCellera Biologics Inc (ABCL) revealed Loss for third quarter of -$40.76 million
The company's earnings came in at -$40.76 million, or -$0.13 per share. This compares with -$57.12 million, or -$0.19 per share, last year.
The company's revenue for the period rose 18.8% to $10.64 million from $8.96 million last year.
AbCellera Biologics Inc earnings at a glance (GAAP) :
-Earnings: -$40.76 Mln. vs. -$57.12 Mln. last year.-EPS: -$0.13 vs. -$0.19 last year.-Revenue: $10.64 Mln vs. $8.96 Mln last year.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....